1. Home
  2. OLB vs BIAF Comparison

OLB vs BIAF Comparison

Compare OLB & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The OLB Group Inc.

OLB

The OLB Group Inc.

SELL

Current Price

$1.41

Market Cap

7.2M

Sector

Technology

ML Signal

SELL

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.07

Market Cap

5.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OLB
BIAF
Founded
1993
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
5.8M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
OLB
BIAF
Price
$1.41
$1.07
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
429.1K
145.1K
Earning Date
11-14-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,639,651.00
$6,776,739.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.52
$20.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$0.69
52 Week High
$2.50
$46.53

Technical Indicators

Market Signals
Indicator
OLB
BIAF
Relative Strength Index (RSI) 79.24 47.37
Support Level $0.31 $0.69
Resistance Level $0.57 $1.08
Average True Range (ATR) 0.15 0.15
MACD 0.07 0.01
Stochastic Oscillator 81.85 62.32

Price Performance

Historical Comparison
OLB
BIAF

About OLB The OLB Group Inc.

The OLB Group Inc is a diversified fintech e-commerce merchant services provider and Bitcoin crypto mining enterprise. It focuses on a suite of products in the merchant services marketplace and seeks to provide integrated business solutions to merchants throughout the United States. Along with its subsidiaries, the company offers a cloud-based business management platform that provides turnkey solutions for merchants to enable them to build and manage their retail businesses, whether online or at a brick-and-mortar location, payment processing solutions, payment gateway, virtual terminal with proprietary business management tools, and crowdfunding solutions. The company has two business segments; Fintech Services which generates key revenue, and the Bitcoin Mining business segment.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: